Herbalife (HLF) Aperçu de l'action
Herbalife Ltd. et ses filiales proposent des produits de santé et de bien-être en Amérique du Nord, au Mexique, en Amérique du Sud et en Amérique centrale, en Europe, au Moyen-Orient, en Afrique, en Chine et dans la région Asie-Pacifique. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 2/6 |
| Performances passées | 1/6 |
| Santé financière | 0/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
HLF Community Fair Values
Create NarrativeSee what 27 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Herbalife Ltd. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$16.60 |
| Plus haut sur 52 semaines | US$20.40 |
| Plus bas sur 52 semaines | US$6.45 |
| Bêta | 0.96 |
| Variation sur 1 mois | 12.77% |
| Variation sur 3 mois | -3.71% |
| Variation sur 1 an | 150.38% |
| Variation sur 3 ans | 22.06% |
| Variation sur 5 ans | -66.55% |
| Évolution depuis l'introduction en bourse | 351.09% |
Nouvelles et mises à jour récentes
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.
HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.Recent updates
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks
The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery
Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.Herbalife's Turnaround Accelerates With Ronaldo's Pro2col
Feb 22HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples
Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples
Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
Jan 22
HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints
The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion
Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced
Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum
Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings
Nov 13The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet
Oct 29At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?
Sep 26A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)
Jul 24There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise
Jun 25Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns
May 28Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye
May 08Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too
Mar 13Herbalife: The Battleground Stock Is Showing Some Turnaround Potential
Feb 24Is It Time To Consider Buying Herbalife Ltd. (NYSE:HLF)?
Feb 19Returns At Herbalife (NYSE:HLF) Appear To Be Weighed Down
Jan 29Herbalife: Down In The Dumps, But Maybe Worth Exploring
Jan 21Investors Still Aren't Entirely Convinced By Herbalife Ltd.'s (NYSE:HLF) Earnings Despite 27% Price Jump
Nov 12We Think You Can Look Beyond Herbalife's (NYSE:HLF) Lackluster Earnings
Nov 06Herbalife: A Top Short Squeeze Idea, Turning Higher In Price
Nov 05What Does Herbalife Ltd.'s (NYSE:HLF) Share Price Indicate?
Nov 01Herbalife: The Biggest Value Trap Of The Moment
Oct 03Herbalife (NYSE:HLF) May Have Issues Allocating Its Capital
Oct 02
Revitalizing Sales Through Innovative Distributor Engagement And Digital Transformation Initiatives
Herbalife's focus on distributor engagement and digital transformation aims to reverse recruitment decline and enhance sales efficiency, potentially boosting revenue.Herbalife Ltd. (NYSE:HLF) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 14Rendement pour les actionnaires
| HLF | US Personal Products | US Marché | |
|---|---|---|---|
| 7D | 2.6% | -1.2% | -0.2% |
| 1Y | 150.4% | -16.2% | 27.6% |
Rendement vs Industrie: HLF a dépassé le secteur US Personal Products qui a rapporté -16.2 % au cours de l'année écoulée.
Rendement vs marché: HLF a dépassé le marché US qui a rapporté 27.6 % au cours de l'année écoulée.
Volatilité des prix
| HLF volatility | |
|---|---|
| HLF Average Weekly Movement | 8.7% |
| Personal Products Industry Average Movement | 9.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
Cours de l'action stable: HLF n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de HLF ( 9% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1980 | 8,500 | Stephan Gratziani | www.herbalife.com |
Herbalife Ltd. et ses filiales proposent des produits de santé et de bien-être en Amérique du Nord, au Mexique, en Amérique du Sud et en Amérique centrale, en Europe, au Moyen-Orient, en Afrique, en Chine et dans la région Asie-Pacifique. Elle propose des produits de gestion du poids, notamment des substituts de repas, des boissons protéinées, des mélanges de boissons, des compléments alimentaires pour la perte de poids, des en-cas sains et des thés qui stimulent le métabolisme ; des produits de nutrition ciblée comprenant des boissons fonctionnelles et des compléments alimentaires et nutritionnels contenant des herbes, des vitamines, des minéraux et d'autres ingrédients naturels ; des produits énergétiques, sportifs et de remise en forme ; et des produits de soins de la peau du visage, de soins du corps et de soins capillaires. L'entreprise fournit également de la documentation, du matériel promotionnel et d'autres supports, tels que des kits de démarrage, des outils de vente et du matériel éducatif.
Herbalife Ltd. Résumé des fondamentaux
| HLF statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$1.65b |
| Bénéfices(TTM) | US$228.30m |
| Recettes(TTM) | US$5.04b |
Le site HLF est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| HLF compte de résultat (TTM) | |
|---|---|
| Recettes | US$5.04b |
| Coût des recettes | US$1.11b |
| Marge brute | US$3.92b |
| Autres dépenses | US$3.69b |
| Les revenus | US$228.30m |
Derniers bénéfices déclarés
Dec 31, 2025
Prochaine date de publication des résultats
May 06, 2026
| Résultat par action (EPS) | 2.21 |
| Marge brute | 77.87% |
| Marge bénéficiaire nette | 4.53% |
| Ratio dettes/capitaux propres | -390.7% |
Quelles ont été les performances à long terme de HLF?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/04/30 22:45 |
| Cours de l'action en fin de journée | 2026/04/30 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Herbalife Ltd. est couverte par 15 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| John Staszak | Argus Research Company |
| Meredith Adler | Barclays |
| Brian Wang | Barclays |